Intraperitoneal131I- and90-labelled monoclonal antibodies for ovarian cancer: Pharmacokinetics and normal tissue dosimetry
- 1 January 1988
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 41 (S3) , 71-76
- https://doi.org/10.1002/ijc.2910410815
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Antibody-guided irradiation of advanced ovarian cancer with intraperitoneally administered radiolabeled monoclonal antibodies.Journal of Clinical Oncology, 1987
- Limitations to the killing of tumours using radiolabelled antibodiesThe British Journal of Radiology, 1987
- External beam pelvic radiotherapy plus intraperitoneal radioactive chronic phosphate in early stage ovarian cancer: A toxic combinationInternational Journal of Radiation Oncology*Biology*Physics, 1985
- Abdominopelvic radiotherapy in ovarian cancer. A 10-year experienceCancer, 1985
- RANDOMISED TRIAL COMPARING TWO COMBINATION CHEMOTHERAPY REGIMENS (HEXA-CAF VS CHAP-5) IN ADVANCED OVARIAN CARCINOMAThe Lancet, 1984
- Detection of human cancer in an animal model using radio-labelled tumour-associated monoclonal antibodiesBritish Journal of Cancer, 1982
- Radioactive chromic phosphate suspension: Studies on distribution, dose absorption, and effective therapeutic radiation in phantoms, dogs, and patientsGynecologic Oncology, 1981
- Differentiation antigens expressed by epithelial cells in the lactating breast are also detectable in breast cancersInternational Journal of Cancer, 1981
- Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycolurilBiochemical and Biophysical Research Communications, 1978
- The binding of calcium and yttrium ions to a glycoprotein from bovine cortical boneBiochemical Journal, 1967